Feedback / Questions
elironrasib (RMC-6291) - Revolution Medicines
daraxonrasib (RMC-6236) - Revolution Medicines
BBO-10203 - BridgeBio Oncology Therapeutics
http://www.ncbi.nlm.nih.gov/pubmed/42457978
Ao Zhang; Xiu-Feng Pang; Xuan-Zheng Xiao; Yun-Jie Wang
Jul 16, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next